Abstract:Background Patients with atrial fibrillation (AF) who undergo radiofrequency catheter ablation (RFCA) necessitate the administration of antiarrhythmic drugs to prevent early recurrence. The clinical outcomes among these patients may be influenced by varying antiarrhythmic regimens. Objectives To identify the risk factors associated with early recurrence and compare the clinical outcomes among different antiarrhythmic regimens in elderly patients with AF following radiofrequency catheter ablation (RFCA) during a 3-month period. Methods A retrospective observational study encompassed 420 elderly patients with AF following RFCA. Baseline data were collected during the initial postoperative visit and clinical outcomes were carefully monitored over a 3-month follow-up period. Logistic regression and Cox-proportional hazard regression analyses were performed to investigate the relationship between various antiarrhythmic regimens and the clinical outcomes. Results Multivariate logistic regression analysis revealed that age ( p = 0.001), left atrial diameter ( p < 0.001), left ventricular diameter ( p = 0.015), reactive hyperemia index (RHI) ( p < 0.001), antiarrhythmic drug ( p < 0.001) and hs-cTnI ( p = 0.017) were independent risk factors of early recurrence. Furthermore, in cox survival regression analysis model, survival rate of early recurrence in the amiodarone group was higher than in the propafenone group (HR 2.30, 95%CI 1.17–4.53, p = 0.016) and in the sotalol group (HR 3.60, 95%CI 2.17–5.95, p < 0.001). Compared to the amiodarone group, the incidence of liver dysfunction was lower in the dronedarone group ( p = 0.046) and the propafenone group ( p = 0.021). The incidence of bradyarrhythmia ( p = 0.003), QT interval prolongation ( p = 0.035) and atrioventricular transmission block ( p = 0.021) were higher in the sotalol group than in the amiodarone group. Conclusion RHI was identified as an independent risk factor for early recurrence among elderly AF patients after RFCA. Compared to amiodarone, propafenone and sotalol exhibited an elevated risk of early recurrence. Although there was no significant difference in early recurrence between amiodarone and dronedarone, dronedarone emerged as the preferred option due to its lower frequency of adverse drug reactions than amiodarone.

Effectiveness of a Triple Antiarrhythmic Drug Strategy for Arrhythmia Recurrence after Persistent Atrial Fibrillation Ablation.

Potential Maintenance Mechanism in Atrial Fibrillation Patients Subject to Different Treatment Procedures: A Preliminary Study Based on a Human Atrial Model

[Effects of Antiarrhythmic Drug Use on Atrial Fibrillation Recurrence in Atrial Fibrillation Patients Post Circumferential Pulmonary Vein Ablation].

Effect of Post-Ablational Antiarrhythmic Drugs on Atrial Fibrillation Recurrence: A Systematic Review and Meta-Analysis

Short-term Antiarrhythmic Drugs After Catheter Ablation for Atrial Fibrillation

Extensive antiarrhythmic drugs after catheter ablation of persistent atrial fibrillation.

Efficacy of Short-Term Antiarrhythmic Drugs Use after Catheter Ablation of Atrial Fibrillation—A Systematic Review with Meta-Analyses and Trial Sequential Analyses of Randomized Controlled Trials

Do extra-pulmonary triggers or autonomic neural activity affect rhythm control by anti-arrhythmic drugs in patients with post-ablation atrial fibrillation recurrence?

Efficacy of Catheter Ablation and Concomitant Antiarrhythmic Drugs on the Reduction of the Arrhythmia Burden in Patients with Long-Standing Persistent Atrial Fibrillation.

Optimal Rhythm-Control Strategy for Recurrent Atrial Tachycardia after Catheter Ablation of Persistent Atrial Fibrillation: a Randomized Clinical Trial

Oral Amiodarone In Blank Period Affects Mmp-9 And Timp-1 Level In Post-Ablation Paroxymal Atrial Fibrillation Patients

Circumferential Pulmonary Vein Isolation Plus Low-Voltage Area Modification in Persistent Atrial Fibrillation

Factors influencing early recurrence of atrial fibrillation among elderly patients following radiofrequency catheter ablation and the impact of different antiarrhythmic regimens

A review regarding the article 'Multidisciplinary management strategies for atrial fibrillation.'

Comparison of catheter ablation and antiarrhythmic drug therapy for atrial fibrillation

Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-analysis of Safety and Efficacy

Radiofrequency Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation: Meta-Analysis of Safety and efficacy1.

Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients

Antiarrhythmic drugs in patients with early persistent atrial fibrillation and heart failure: results of the RACE 3 study

Multi-centre, Prospective Randomized Comparison of Three Different Substrate Ablation Strategies for Persistent Atrial Fibrillation

Relationship between amiodarone response prior to ablation and 1-year outcomes of catheter ablation for atrial fibrillation